Clinical Trials Logo

Clinical Trial Summary

Populations in precarious situations or with low socio-economic status have an increased risk of diabetes and accelerated aging. According to the population studied, the elements that can explain these health inequalities are not unequivocal and remain poorly known. The north of France, particularly affected by socio-economic disparities, has a prevalence of diabetes among the highest in metropolitan France. This is why investigators want to study the clinical, biological, social and behavioural risk factors of the entry into diabetes and accelerated aging among a large population in the North of France. This study aims to characterize the population (among which a majority (55%) suffers from precarious conditions) who come to carry out their health examination at the Pasteur Institute in Lille in order to study the risk factors to better explain these health inequalities. This research consists of a main descriptive observational, cross-sectional study carried out on 2233 volunteers (main group) over 18 months, and a complementary analytical case-control study that will be offered to 216 participants (sub-group).


Clinical Trial Description

Primary Objective : Assessment of Prevalence of Prediabetes and Diabetes by Socio-Economic Status Primary efficacy endpoint : Fasting glucose value based on EPICES score : Glycemia: - Normal: fasting glucose ≤ 1g/l - Prediabetes: fasting glucose >1 g/l and ≤1.25 g/l - Diabetes: fasting glucose >1.25 g/l EPICES score: quintiles of score distribution (Q1 to Q5) Secondary Objectives specific to the main group: - Characterize the population and analyze the risk factors (clinical, biological, socio-economic and behavioural) of diabetes and prediabetes in this population. - Study the level of biological ageing and factors associated with accelerated ageing. - Estimate the risk of (pre)diabetes and accelerated aging based on socio-economic profile. Secondary Objectives specific to the sub-group: - Assess the impact of economic, social and cultural capital on health in terms of diabetes and accelerated aging. - Analyze the effect on diabetes and accelerated aging of the exposures assessed: body composition, physical activity, arterial rigidity, cognitive status, psychiatric disorders, fragility, pain. Secondary endpoints specific to the main group: : - Prevalence ratio of diabetes and prediabetes calculated for: - Clinical, paraclinical parameters (Oral examination, Muscle strength,Advanced glycation products) and anthropometric parameters (medical history, height, weight, BMI, Waist and hip circumference, Neck circumference, body composition measurement, Systolic and diastolic blood pressure, Unipedal stance test). - Biological (blood and genetic). - Behavioural/environmental predictors: (socio-economic status, physical activity(RICCI GAGNON), diet(HDI), quality of life (MQLI), stress-anxiety(PSS), toxic habits, fragility(FRIED) ). - Assessment of the level of ageing - Biological Aging Marker: DNAmPhenoAge (DNA methylation phenotypic age) - Accelerated ageing: age regression DNAmPhenoAge on chronological age - Analysis of age-related parameters (inflammatory, renal, hormonal, body composition measurement, fragility, advanced glycation products, muscle strength) and correlation with methylation rate and DNAmPhenoAge. - Prevalence ratio of (pre)diabetes and accelerated aging according to socio-economic status - Evaluation of (pre)diabetes: fasting blood sugar - Accelerated Aging Assessment: DNAm PhenoAge - Social Status Assessment: EPICES Q1 to Q5 Score - Assessment of economic status: Income level Secondary endpoints specific to the subgroup: - Risk (OR) of (pre)diabetes and accelerated aging according to social, economic, cultural and marital status - Evaluation of (pre)diabetes: fasting blood sugar - Accelerated Aging Assessment: DNAmPhenoAge - Socio-economic and cultural criteria - Social status (EPICES score) - Economic status (income) - Cultural status (semi-directive interview) - Professional status (educational level, socio-professional category, marital status) - Risk (OR) of (pre)diabetes and accelerated aging for assessed exposures: - Evaluation of (pre)diabetes: fasting blood sugar - Accelerated Aging Assessment: DNAmPhenoAge - Exposure Assessment - Arterial Stiffness Index - Body composition (mineral density, lean mass, fat mass) (DEXA test) - Insomnia Severity Index (ISI) - Cognitive Status (MOCA) - Physical Activity (GPAQ Questionnaire) - Alcohol consumption (FACE) - Psychiatric disorders (MINI) - Fragility (REFS score) - Pain Scale (EVA) ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05717491
Study type Observational
Source Institut Pasteur de Lille
Contact
Status Completed
Phase
Start date December 14, 2021
Completion date March 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT05594446 - Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
Completed NCT03975309 - DHS MIND Metabolomics
Completed NCT01855399 - Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes N/A
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05007990 - Caregiving Networks Across Disease Context and the Life Course
Active, not recruiting NCT04420936 - Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program N/A
Recruiting NCT03549559 - Imaging Histone Deacetylase in the Heart N/A
Completed NCT04903496 - Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
Completed NCT01437592 - Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects Phase 1
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT03390179 - Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Recruiting NCT05294822 - Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes N/A
Completed NCT04427982 - Dance and Diabetes/Prediabetes Self-Management N/A
Completed NCT02356848 - STEP UP to Avert Amputation in Diabetes N/A
Completed NCT03292185 - A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects Phase 1
Active, not recruiting NCT05477368 - Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes N/A
Completed NCT04496401 - PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus Phase 4